Taking people in DenmarkPhase 1
Tests ADP-TILIL7 in adults with advanced melanoma
Tests ADP-TILIL7 in adults with locally advanced or metastatic melanoma.
Key facts
- Who runs it
- Herlev Hospital
- Where
- Herlev, DenmarkSee the site
- Trial code
- Registry title
- ADP-TILIL7
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 10 people, planned
- Started
- 15 Aug 2024
- Expected to end
- 1 Mar 2028
- Type of study
- Interventional
- Record updated
- 25 June 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with locally advanced or metastatic melanoma. The record gives no other details.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Locally advanced or metastatic melanoma
Where in Denmark
- Herlev HospitalHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests ADP-TILIL7 in adults with advanced melanomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 25 June 2024